The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

AbbVie's Allergan and Evolus have been locked in a yearslong trade secrets fight involving the two drugmakers' South Korean partners and blockbuster Botox. Despite some early promise for Evolus, a U.S ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

Shares of Irvine-based Allergan Inc. jumped Monday as Wall Street got its first crack at the stock after word Friday that the company’s flagship Botox drug was approved as a treatment for migraine ...

For Allergan Inc., a subtle offense has proved the best defense in the court of public opinion over Botox. Observers give the Irvine drug maker good marks for its strategy in support of Allergan’s ...

We’re adding branded drug giant Allergan (AGN), which is based in Ireland, to our model portfolio, says biotech and healthcare sector expert Bret Jensen, editor of Investors Alley’s Biotech Gems.

Botox is a prescription drug used to reduce wrinkles and treat medical conditions such as overactive bladder and chronic migraine. The drug comes as a powder and is diluted with saline before it’s ...

NEW YORK (Reuters) - Regulators seem inclined to approve Allergan Inc's wrinkle drug Botox to prevent migraine headaches in millions of Americans, industry analysts said, based on information the ...

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will lay claim to a new $176 million plant at the site in Ireland where the blockbuster is ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million. The lawsuit, filed by Ireland-based ...